During the past decade, South Jersey Infectious Disease conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 18 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Jersey Infectious Disease" #1 sponsor was "Gilead Sciences" with 18 trials, followed by "Pfizer" with 6 trials sponsored, "BioNTech SE" with 3 trials sponsored, "Basilea Pharmaceutica" with 1 trials sponsored and "Clear Creek Bio, Inc." with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Jersey Infectious Disease" #1 collaborator was "Pfizer" with 3 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "South Jersey Infectious Disease" are "HIV Infections" (9 trials), "HIV-1 Infection" (7 trials), "HIV" (5 trials), "Acquired Immunodeficiency Syndrome" (4 trials) and "COVID-19" (3 trials). Many other conditions were trialed in "South Jersey Infectious Disease" in a lesser frequency.

Most popular intervention types in "South Jersey Infectious Disease" are "Drug" (29 trials), "Biological" (9 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "FTC/TDF" (6 trials), "RTV" (4 trials), "Stribild" (4 trials) and "ATV" (3 trials). Other intervention names were less common.

The vast majority of trials in "South Jersey Infectious Disease" are 38 trials for "All" genders.

Currently, there are NaN active trials in "South Jersey Infectious Disease". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in South Jersey Infectious Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in South Jersey Infectious Disease, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".